Benitec Biopharma Ltd ADR
(BNTC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 50,929 | 14,156 | 20,388 | 25,877 | 2,490 |
| Receivables | 229 | 53 | 53 | 53 | 55 |
| Other current assets | 516 | 157 | 355 | 482 | 1,184 |
| TOTAL | $51,674 | $14,366 | $20,796 | $26,412 | $3,729 |
| Non-Current Assets | |||||
| PPE Net | 179 | 204 | 51 | 68 | 87 |
| Investments And Advances | 25 | 25 | 25 | 25 | 25 |
| Other Non-Current Assets | 332 | 404 | 481 | 548 | 623 |
| TOTAL | $536 | $633 | $557 | $641 | $735 |
| Total Assets | $52,210 | $14,999 | $21,353 | $27,053 | $4,464 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,165 | 2,628 | 4,937 | 3,794 | 3,231 |
| TOTAL | $4,924 | $3,437 | $5,746 | $4,534 | $3,978 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 38 | 0 | 0 | 0 | 0 |
| TOTAL | $38 | $62 | $137 | $211 | $284 |
| Total Liabilities | $4,962 | $3,499 | $5,883 | $4,745 | $4,262 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,556 | 9,367 | 2,592 | 2,572 | 2,547 |
| Common Shares | 1 | N/A | N/A | N/A | N/A |
| Retained earnings | -190,259 | -184,920 | -180,641 | -173,843 | -167,889 |
| Other shareholders' equity | -892 | -835 | -952 | -780 | -830 |
| TOTAL | $47,248 | $11,500 | $15,470 | $22,308 | $202 |
| Total Liabilities And Equity | $52,210 | $14,999 | $21,353 | $27,053 | $4,464 |